Cytokinetics adds pharma veteran Landry to board ahead of drug launch
SOUTH SAN FRANCISCO - Cytokinetics , Incorporated (NASDAQ:CYTK), currently valued at approximately $5 billion in market capitalization, has announced the appointment of Robert E. Landry to its Board ...
manilatimes3h
Cytokinetics Names Robert E. Landry to Board of Directors
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the appointment of Robert E. Landry to its Board of Directors. Mr. Landry brings over three decades of financial and operational expertise in ...
The Journal News6d
New science research fair set for middle schoolers from Westchester, Rockland, Putnam
A new in-person science and engineering research fair for middle school students from Westchester, Rockland and Putnam counties will premier on Saturday, April 26 at Edgemont High School. The ...
BioSpace7d
Regeneron Misses on Eylea, Dupixent Sales; Issues First-Ever Dividends
Despite lackluster sales of Eylea’s high-dose formulation and Sanofi-partnered Dupixent, Regeneron beat Q4 forecasts overall ...
NBC News15d
China says it will send its vice president to Trump's inauguration
HONG KONG — China is sending Vice President Han Zheng to President-elect Donald Trump’s inauguration in Washington, Chinese state media reported Friday, the first time a senior Chinese leader ...
Nasdaq18d
America’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at Prestigious Regeneron Science Talent Search
Yancopoulos, M.D., Ph.D., co-Founder, co-Chairman, President and Chief Scientific Officer of Regeneron, who was a top winner in 1976. “Regeneron now helps millions of people around the world ...
NDTV18d
"Chose Not To Pardon Myself": Trump Slams Biden In 1st Interview As President
US President Donald Trump on Wednesday sat for his first interview since returning to the White House and targetted his predecessor former President Joe Biden for issuing several pardons for ...
Morningstar19d
Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report– Hagens Berman
Regeneron Pharmaceuticals, Inc. (REGN) Securities Class Action: The litigation is focused on the propriety of Regeneron’s statements about its compliance with applicable rules and regulations ...
Morningstar20d
Shareholders that lost money on Regeneron Pharmaceuticals, Inc.(REGN) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN) of a class action securities ...
Yahoo Finance20d
REGENERON EXPANDS PRESENCE IN CANADA BY OPENING ITS FIRST HEADQUARTERS TO BETTER SERVE NEEDS OF CANADIANS WITH SERIOUS DISEASES
Country Manager (Oncology), Regeneron Canada; Justin Holko, Senior Vice President, Global Oncology/Hematology Commercial Business Unit, Regeneron; Acher Elfassy, Country Manager (Immunology ...
Fox Business21d
President Trump, his administration and Congressional leaders: their salaries
President Donald Trump and Vice President JD Vance took their oaths of office on Monday, marking the official start of their administration. During his inauguration speech in the U.S. Capitol ...
Mint21d
Donald Trump Inauguration Highlights: US President makes dramatic move, tosses pens after signing executive orders
Premium Donald Trump Inauguration LIVE Updates: US President Donald Trump made a dramatic gesture after signing the freedom of speech executive order on the inauguration day of his second ...